Philadelphia CyberKnife Now Accepting Metastatic Cancer Patients in a National Phase I Clinical Trial


Philadelphia CyberKnife recently participated with NRG Oncology in the NRG-BR001 protocol, a Phase I Study of Stereotactic Body Radiotherapy for the Treatment of Multiple Metastases, and successfully completed their first patient treatment in May 2015. NRG Oncology is a non-profit research organization formed to conduct oncologic clinical research and to broadly disseminate study results for informing […]


Learn More